Literature DB >> 24450344

Laparoscopic abdominosacral resection for locally advanced primary rectal cancer after treatment with mFOLFOX6 plus bevacizumab, followed by preoperative chemoradiotherapy.

Toshiya Nagasaki1, Takashi Akiyoshi, Masashi Ueno, Yosuke Fukunaga, Satoshi Nagayama, Yoshiya Fujimoto, Tsuyoshi Konishi, Toshiharu Yamaguchi.   

Abstract

Abdominosacral resection may be the only curative procedure for locally advanced rectal cancer involving the presacral fascia or sacrum. Multimodal therapy might be necessary to prevent local and distant recurrence for such tumors. A 67-year-old man was diagnosed with locally advanced rectal cancer widely involving the right pelvic sidewall and presacral fascia near the S4/5 junction on the right posterolateral side. We performed laparoscopic abdominosacral resection (S4/5) with en bloc right lateral lymph node dissection and seminal vesicle resection to obtain a clear resection margin after systemic chemotherapy with mFOLFOX6 (oxaliplatin, leucovorin, and 5-fluorouracil) plus bevacizumab, followed by preoperative chemoradiotherapy. The total operative time was 660 min, and the estimated blood loss was 550 mL. The final pathological findings revealed no residual cancer cells (pathological complete response). Laparoscopic abdominosacral resection appears to be safe and feasible in selected patients.
© 2014 Japan Society for Endoscopic Surgery, Asia Endosurgery Task Force and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  Advanced rectal cancer; laparoscopic abdominosacral resection; laparoscopic surgery

Mesh:

Substances:

Year:  2014        PMID: 24450344     DOI: 10.1111/ases.12068

Source DB:  PubMed          Journal:  Asian J Endosc Surg        ISSN: 1758-5902


  7 in total

1.  Laparoscopic pelvic sidewall dissection with combined resection of internal iliac vessels for local recurrence of rectal cancer.

Authors:  S Hasegawa; G Nishikawa; K Hida; K Kawada; Y Sakai
Journal:  Tech Coloproctol       Date:  2015-07-26       Impact factor: 3.781

2.  Laparoscopic salvage surgery for locally recurrent rectal cancer.

Authors:  Toshiya Nagasaki; Takashi Akiyoshi; Masashi Ueno; Yosuke Fukunaga; Satoshi Nagayama; Yoshiya Fujimoto; Tsuyoshi Konishi; Toshiharu Yamaguchi
Journal:  J Gastrointest Surg       Date:  2014-05-17       Impact factor: 3.452

3.  Safety of Laparoscopic Pelvic Exenteration with Urinary Diversion for Colorectal Malignancies.

Authors:  Atsushi Ogura; Takashi Akiyoshi; Tsuyoshi Konishi; Yoshiya Fujimoto; Satoshi Nagayama; Yosuke Fukunaga; Masashi Ueno
Journal:  World J Surg       Date:  2016-05       Impact factor: 3.352

Review 4.  Technical feasibility of laparoscopic extended surgery beyond total mesorectal excision for primary or recurrent rectal cancer.

Authors:  Takashi Akiyoshi
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

5.  The Feasibility and Efficacy of Laparoscopic Extended Total Mesorectal Excision for Locally Advanced Lower Rectal Cancer.

Authors:  Takashi Nonaka; Akiko Fukuda; Kyoichiro Maekawa; Shigeki Nagayoshi; Takayuki Tokunaga; Mitsutoshi Takatsuki; Tomoo Kitajima; Ken Taniguchi; Hikaru Fujioka
Journal:  In Vivo       Date:  2018 May-Jun       Impact factor: 2.155

6.  Laparoscopic anterior pelvic exenteration for locoregionally advanced rectal cancer directly invading the urinary bladder: A case report of low anterior resection with en bloc cystectomy for sphincter preservation.

Authors:  Hidenobu Ishizaki; Shinya Nakashima; Takeomi Hamada; Takahiro Nishida; Naoki Maehara; Takuto Ikeda; Hiromasa Tsukino; Shoichiro Mukai; Toshiyuki Kamoto; Kazuhiro Kondo
Journal:  Asian J Endosc Surg       Date:  2015-08

7.  Resection of "down-staged" advanced hepatocellular carcinoma after treatment with the VEGFR2 inhibitor apatinib: five cases report.

Authors:  Zhenyu Hou; Keyun Zhu; Xuejiao Yang; Hongyuan Zhou; Ping Chen; Ge Yu; Xiaolin Zhu; Yunlong Cui; Tianqiang Song; Qiang Li; Huikai Li; Ti Zhang
Journal:  Transl Cancer Res       Date:  2020-08       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.